Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: Results from a tertiary care center

Journal of Crohn's and Colitis

Volumn 7, Issue 12, 2013, Pages

  Tinsley, Andrew ^a   Naymagon, Steven ^b   Enomoto, Laura M ^a   Hollenbeak, Christopher S ^a,c   Sands, Bruce E ^b   Ullman, Thomas A ^b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Deep venous thrombosis; ; Inflammatory bowel disease; ; Prophylaxis; Pulmonary embolism; ; Ulcerative colitis; ; Venous thromboembolism;

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; CHILD; COHORT ANALYSIS; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICAL SERVICE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SURGERY; SURGICAL PATIENT; TERTIARY HEALTH CARE; ULCERATIVE COLITIS; VENOUS THROMBOEMBOLISM;

DEEP VENOUS THROMBOSIS;; INFLAMMATORY BOWEL DISEASE;; PROPHYLAXIS; PULMONARY EMBOLISM;; ULCERATIVE COLITIS;; VENOUS THROMBOEMBOLISM;;

ADOLESCENT; ADULT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; FEMALE; HEPARIN; HOSPITALIZATION; HUMANS; INFANT; INTERNAL MEDICINE; MALE; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURGERY DEPARTMENT, HOSPITAL; TERTIARY CARE CENTERS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84887615923     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.05.002     Document Type: Article

References (24)

1. Peyrin-Biroulet L., Loftus E.V., Colombel J.F., Sandborn W.J. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts. Inflamm Bowel Dis 2011, 17(1):471-478.
2. Andrews H.A., Lewis P., Allan R.N. Mortality in Crohn's disease - a clinical analysis. Q J Med 1989, 71(265):399-405.
3. Grainge M.J., West J., Card T.R. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 2010, 375(9715):657-663.
4. Bernstein C.N., Blanchard J.F., Houston D.S., Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001, 85(3):430-434.
5. Kappelman M.D., Horvath-Puho E., Sandler R.S., et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut 2011, 60(7):937-943.
6. Nguyen G.C., Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008, 103(9):2272-2280.
7. Murthy S.K., Nguyen G.C. Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Am J Gastroenterol 2011, 106(4):713-718.
8. Samama M.M., Cohen A.T., Darmon J.Y., et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999, 341(11):793-800.
9. Leizorovicz A., Cohen A.T., Turpie A.G., et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004, 110(7):874-879.
10. Kornbluth A., Sachar D.B. Gastroenterology PPCotACo. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010, 105(3):501-523.
11. Kahn S.R., Lim W., Dunn A.S., et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012, 141(2 Suppl.):e195S-e226S.
12. Travis S.P., Stange E.F., Lémann M., et al. European evidence-based consensus on the management of ulcerative colitis: current management. J Crohns Colitis 2008, 2(1):24-62.
13. Mowat C., Cole A., Windsor A., et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011, 60(5):571-607.
14. Cohen A.T., Tapson V.F., Bergmann J.F., et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008, 371(9610):387-394.
15. Yu H.T., Dylan M.L., Lin J., Dubois R.W. Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm 2007, 64(1):69-76.
16. Amin A., Stemkowski S., Lin J., Yang G. Thromboprophylaxis rates in US medical centers: success or failure?. J Thromb Haemost 2007, 5(8):1610-1616.
17. Tapson V.F., Decousus H., Pini M., et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 2007, 132(3):936-945.
18. Amin A., Spyropoulos A.C., Dobesh P., et al. Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start). J Thromb Thrombolysis 2010, 29(3):326-339.
19. Amin A.N., Stemkowski S., Lin J., Yang G. Inpatient thromboprophylaxis use in U.S. hospitals: adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patients. J Hosp Med 2009, 4(8):E15-E21.
20. Tinsley A., Naymagon S., Trindade A.J., Sachar D.B., Sands B.E., Ullman T.A. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States. J Clin Gastroenterol 2013, 47(1):e1-e6.
21. Sam J.J., Bernstein C.N., Razik R., Thanabalan R., Nguyen G.C. Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease. Dig Dis Sci 2013, 58(1):46-52.
22. Kakkar A.K., Cohen A.T., Tapson V.F., et al. Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients. Ann Surg 2010, 251(2):330-338.
23. Folwaczny C., Wiebecke B., Loeschke K. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol 1999, 94(6):1551-1555.
24. Evans R.C., Wong V.S., Morris A.I., Rhodes J.M. Treatment of corticosteroid-resistant ulcerative colitis with heparin - a report of 16 cases. Aliment Pharmacol Ther 1997, 11(6):1037-1040.